Combination of Cryolipolysis and Aerobic Exercise in Reducing Abdominal Fat

May 2, 2023 updated by: Heba Ebrahim Elsayed Mohamed, Cairo University

The Effect of Combination Between Cryolipolysis and Aerobic Exercise in Reducing Abdominal Adiposity in Obese Subjects

The purpose of the study is To investigate the adding effect of Cryolipolysis to aerobic exercise with low caliorie diet on waist-to-hip ratio , ultrasonography, body mass index and skin fold of subcutaneous fat tissue in abdominal adiposity in obese subjects

Study Overview

Status

Completed

Conditions

Detailed Description

Obesity is a serious disease marked by an increase in body weight of at least 20% over the ideal weight due to an accumulation of body fat.

The prevalence of obesity has hit epidemic levels over the past few decades, and numerous obesity-related illnesses, including heart conditions, certain types of cancer, and diabetes, have risen concurrently. Weight loss through lifestyle modification, including a hypocaloric diet and/or increased physical exercise, along with behavioural techniques to support these changes, is the basis for treating or preventing these diseases through therapeutic intervention. Such methods rarely result in an obese person reaching a normal body weight because the typical weight reduction from lifestyle change is between 5 and 10% of baseline weight.

Recently, studies have used numerous devices, including cavitation, radiofrequency, cryolypolysis, and other many devices, according to the World Health Organization, to solve this issue.

The FDA has approved the cryolipolysis device for cutaneous cooling as well as a number of other uses. Cryolipolysis is a novel non-invasive technique for the selective reduction of fat cells with controlled, localised cooling.

Clinicians use the waist measurement and waist-to-hip ratio to assess abdominal obesity. These actions have a clear correlation to many vascular diseases, including atherosclerosis and the risk of developing acute coronary syndromes.

Typically, low-calorie diets are low in fat ( 30% of energy intake), high in carbohydrates (55-60% of total daily energy consumption), and energy-reduced (deficit of 2100-4200 kJ/d: ) minimum of 4200-5040 kJ/d for women and 5040- 5880 kJ/d for men) Due to the acutely high energy cost and ability to increase fat utilization, aerobic exercise is frequently recommended in conjunction with calorie restriction. Numerous studies examined the effects of modest caloric restriction alone or in combination with aerobic exercise.According to studies, a walk/jog programme enhanced body fat reduction compared to a group that only followed a diet.

There is a gap in the literature regarding combining cryolipolysis and aerobic exercise for losing weight, particularly abdominal adiposity, despite the fact that numerous studies have supported the efficacy of each on weight loss. Therefore, the goal of this research is to ascertain whether losing abdominal adiposity would be more successful when cryolipolysis and aerobic exercise were combined.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Heba Ebrahim Elsayed Mohamed

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Body mass index of the subjects range from (30-40)kg/m2
  • subjects have abdominal adiposity

Exclusion Criteria:

  • patients with liver and kidney diseases
  • patients who have sensitivity to cold
  • patients who have auto-immune disease
  • patients after caesarean section
  • impaired peripheral circulation
  • Raynauds disease
  • pregnant or lactating women within 6 months
  • paroxysmal cold hemogobulinemia
  • individuals who had metabolic derangement such as type 2 dibetes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cryolipolysis and aerobic exercise
in this arm we combined between Three Max cool shaping Cryolipolysis device (ESM-8l00MO; EunSung global, Korea) was utilised. Vacuum controllable heads with cold temperatures ranging from (-10to 5)°C were adjusted according to each patient's tolerance, after careful patient sensation examination and vital sign evaluation before and after each session ,they got two sessions and walked from 30 to 60 minutes in nearby park.Two Cryolipolysis treatments totaling 45 minutes each were administered to each patient in the experimental group at the hypogastrium region, 5 cm below the umbilicus, using an anti-freezing membrane to prevent cold burn, in order to conduct the treatment

the patients in this arm adjusted low calorie diet . According to the Recommended Dietary Intake (RDI), the low-calorie diet plan with three carefully calculated meals had a balanced macronutrient quantity of carbohydrate and protein, was low in fat, and was abundant in fruits, vegetables, and dietary fibres.

they got two cryolipolysis sessions,one session in the month ,they got two sessions in two months,then took our outcome measures with walking 60 minutes in the park

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the waist-to-hip ratio
Time Frame: 2 months
by tape measurment
2 months
abdominal skin fold
Time Frame: 2 months
by fat caliper
2 months
body mass index
Time Frame: 2 months
by equation of world health organization
2 months
fat thickness
Time Frame: 2 months
by ultrasonography
2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2022

Primary Completion (Actual)

February 22, 2023

Study Completion (Actual)

February 22, 2023

Study Registration Dates

First Submitted

April 23, 2023

First Submitted That Met QC Criteria

May 2, 2023

First Posted (Actual)

May 10, 2023

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 2, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • cryolipolysis

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Abdominal Obesity

Clinical Trials on cryolipolysis and aerobic exercise

Subscribe